Related Experiment Videos
Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis
B A Carneiro-Filho1, I P F Lima, D H Araujo
1Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, Ceara, Brasil.
Digestive Diseases and Sciences
|March 3, 2004
Summary
Methotrexate chemotherapy causes significant intestinal damage, increasing permeability and electrolyte secretion. This study reveals key insights into chemotherapy-induced mucositis and its impact on gut function.
Area of Science:
- Gastroenterology
- Oncology
- Pharmacology
Background:
- Chemotherapy-induced mucositis is a severe side effect lacking effective treatments.
- Understanding its impact on intestinal function is crucial for developing interventions.
Purpose of the Study:
- Investigate small intestine barrier function and transport in a methotrexate-induced mucositis model.
- Correlate functional changes with histological damage.
Main Methods:
- Wistar rats received methotrexate to induce mucositis.
- Intestinal permeability assessed via lactulose and mannitol excretion.
- In vivo intestinal perfusion evaluated water and electrolyte transport.
Main Results:
- Methotrexate induced dose-dependent weight loss and reduced food intake.
- Significant villous atrophy and crypt elongation observed in the small intestine.
- Increased sodium and potassium secretion and reduced absorptive surface area noted.
Conclusions:
- Methotrexate significantly disrupts small bowel permeability and electrolyte transport.
- Functional alterations correlate with substantial histological damage.
- This model provides insights into chemotherapy-induced mucositis pathophysiology.